BD cautions about certain neXus V700 infusion pumps
Becton, Dickinson and Company (BD) has issued a warning about potential malfunctions in some neXus V700 infusion pumps. The warning comes after reports of unexpected shutdowns and other issues with the devices.
The neXus V700 infusion pump is used to deliver fluids, medications, and nutrients to patients in a controlled manner. However, BD has found that some units may experience a software malfunction that causes the pump to shut down unexpectedly. This could lead to under or over-infusion of medications, potentially putting patients at risk.
In response to these reports, BD is advising healthcare providers to closely monitor patients who are receiving infusions with the neXus V700 pump. They are also recommending that healthcare facilities consider using alternative infusion pumps until the issue is resolved.
BD is working with the Food and Drug Administration (FDA) to address the problem and determine the best course of action. In the meantime, they are asking healthcare providers to report any incidents or adverse events related to the neXus V700 pump.
Patients who are currently using the neXus V700 infusion pump should speak with their healthcare provider about any concerns they may have. It’s important to always be vigilant when it comes to medical devices and to report any issues to ensure patient safety.
BD apologizes for any inconvenience or risk that this may cause to patients and healthcare providers. They are committed to resolving the issue promptly and ensuring the safety and effectiveness of their products.
In conclusion, BD is warning healthcare providers about potential malfunctions in some neXus V700 infusion pumps. Patients should speak with their healthcare providers about any concerns and report any incidents or adverse events. BD is working with the FDA to address the issue and ensure patient safety.
#warns #neXus #V700 #infusion #pumps